Redefining Alzheimer’s development by mapping disease sequences

RESEARCH-ALZHEIMER'S-SYMPTOMS Study Identifies Four Distinct Clusters of Symptoms That Can Possibly Advance to Alzheimer's

Get latest articles and stories on India at LatestLY. A study has identified four distinct clusters of symptoms, including psychiatric and cardiovascular, that can progressively lead to Alzheimer's disease -- an ageing-related condition in which memory and speech steadily declines, eventually disrupting daily activities. India News | RESEARCH-ALZHEIMER'S-SYMPTOMS Study Identifies Four Distinct Clusters of Symptoms That Can Possibly Advance to Al…

Redefining Alzheimer’s development by mapping disease sequences

UCLA's study identifies distinct Alzheimer's disease trajectories, emphasizing the role of shared risk factors in early detection and targeted interventions.

Canada is falling behind on Alzheimer's disease treatments

Andrew Frank and Katherine C. Pearson, QUOI Media Alzheimer’s disease is an insidious and relentless loss of memory and thinking, accompanied by a gradual yet devastating deterioration in ability to function independently. It’s a terrifying diagnosis for patients and families alike. Dementia is defined as a loss of memory or thinking, which takes away daily […]

What to know about the new Alzheimer’s blood test

In May, the Food and Drug Administration gave the green light to a new blood test for Alzheimer’s disease that researchers say helps physicians diagnose the progressive neurological disorder earlier and at a lower cost.  It is the first FDA-cleared in vitro diagnostic test to identify patients with amyloid plaques associated with the disease in adults aged 50 years and older and exhibiting signs and symptoms of the disease, according to its manu…

Quest to offer FDA-approved Alzheimer’s blood test

Quest Diagnostics will soon begin offering a new blood-based in-vitro diagnostic test for Alzheimer’s. The disease affects nearly 7 million Americans.  The Lumipulse G pTau 217/β-Amyloid 1-42 Plasma Ratio IVD test from Fujirebio is the first blood-based IVD test approved by the U.S. Food and Drug Administration to aid in identifying patients with amyloid pathology associated with Alzheimer’s.  The test will be available to physicians and biophar…

Alzheimer’s Is Not Random: 4 Early Warning Patterns Identified

The paper published in eBioMedicine describes how the scientists identified the four distinct sequential pathways by analyzing longitudinal health data from close to 25,000 patients and validated their findings in the nationally diverse All of Us Research Program. Rather than focusing on individual risk factors, this study mapped sequential diagnostic patterns that reveal how conditions progress towards Alzheimer’s disease (AD). Their findings o…